Elotuzumab
| Elotuzumab | |
|---|---|
| Term | Elotuzumab |
| Short definition | Elotuzumab (EH-loh-TOO-zoo-mab) A drug used with dexamethasone and either lenalidomide or pomalidomide to treat adults with multiple myeloma. It is used in patients whose cancer has already been treated with other cancer treatments. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Elotuzumab - (pronounced) (EH-loh-TOO-zoo-mab) A drug used with dexamethasone and either lenalidomide or pomalidomide to treat adults with multiple myeloma. It is used in patients whose cancer has already been treated with other cancer treatments. Elotuzumab attaches to a protein called CS1, which is found on myeloma cells and some types of immune cells. Elotuzumab can block CS1 and help the immune system kill cancer cells. It's a type of monoclonal antibody. Also called Empliciti and HuLuc63
External links
- Medical encyclopedia article on Elotuzumab
- Wikipedia's article - Elotuzumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski